Literature DB >> 23773012

The progress of cognitive decline in newly diagnosed MS patients.

E Hankomäki1, J Multanen, E Kinnunen, P Hämäläinen.   

Abstract

OBJECTIVES: Cognitive impairment occurs in multiple sclerosis already in the early stages of the disease. Less is known about the evolution of cognitive decline, especially in newly diagnosed MS patients. The results of existing studies are contradictory in that both cognitive preservation and progressive deterioration have been reported. The purpose of this study was to examine how cognitive impairment evolves over time in the early stages of MS.
MATERIAL AND METHODS: At baseline, the participants were 36 newly diagnosed MS patients and 37 controls. A group of 30 patients were followed longitudinally at a mean test-retest interval of 6.1 years. The test battery covered attention, information processing, memory and learning, verbal and motor functions and reasoning.
RESULTS: There was a significant decline in divided attention (dual task) and information-processing speed (SDMT) at follow-up, but no significant deterioration in overall cognitive performance.
CONCLUSIONS: Overall cognitive functioning remained quite stable during the 6-year follow-up, whereas divided attention and processing speed deteriorated. However, deterioration in performance on the SDMT and the dual task does not seem to indicate more extensive cognitive deterioration. Given the impact of cognitive impairment on patients' quality of life, early detection of its occurrence in MS is extremely important.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cognition; early stage; multiple sclerosis; neuropsychology

Mesh:

Year:  2013        PMID: 23773012     DOI: 10.1111/ane.12161

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remitting multiple sclerosis.

Authors:  Peter Joseph Jongen; Keith Wesnes; Björn van Geel; Paul Pop; Evert Sanders; Hans Schrijver; Leo H Visser; H Jacobus Gilhuis; Ludovicus G Sinnige; Augustina M Brands
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

2.  Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.

Authors:  S Migliore; A Ghazaryan; I Simonelli; P Pasqualetti; F Squitieri; G Curcio; D Landi; M G Palmieri; F Moffa; M M Filippi; F Vernieri
Journal:  Behav Neurol       Date:  2017-08-15       Impact factor: 3.342

Review 3.  Cognitive Dysfunction in the Early Stages of Multiple Sclerosis-How Much and How Important?

Authors:  Magdalena Oset; Mariusz Stasiolek; Mariola Matysiak
Journal:  Curr Neurol Neurosci Rep       Date:  2020-05-22       Impact factor: 5.081

4.  Remotely Supervised Transcranial Direct Current Stimulation Increases the Benefit of At-Home Cognitive Training in Multiple Sclerosis.

Authors:  Leigh Charvet; Michael Shaw; Bryan Dobbs; Ariana Frontario; Kathleen Sherman; Marom Bikson; Abhishek Datta; Lauren Krupp; Esmail Zeinapour; Margaret Kasschau
Journal:  Neuromodulation       Date:  2017-02-22

5.  Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis.

Authors:  Mariana López-Góngora; Antonio Escartín; Saul Martínez-Horta; Ramón Fernández-Bobadilla; Luis Querol; Sergio Romero; Miquel Àngel Mañanas; Jordi Riba
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

6.  Decline of Neuropsychological Abilities in a Large Sample of Patients with Multiple Sclerosis: A Two-Year Longitudinal Study.

Authors:  Martina Borghi; Sara Carletto; Luca Ostacoli; Francesco Scavelli; Lorenzo Pia; Marco Pagani; Antonio Bertolotto; Simona Malucchi; Alessio Signori; Marco Cavallo
Journal:  Front Hum Neurosci       Date:  2016-06-08       Impact factor: 3.169

7.  Phototest for neurocognitive screening in multiple sclerosis.

Authors:  Joana Pinto; Emanuela Lopes; Gerly Gonçalves; Ângela Silva; Bruno Peixoto
Journal:  Dement Neuropsychol       Date:  2016 Jan-Mar
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.